UC team studies link between Parkinson's disease and depression

A patient who receives a diagnosis of Parkinson's disease might become depressed, and understandably so. But does the depression then exacerbate the progression of Parkinson's?

That's one of the questions a team of University of Cincinnati researchers is studying, with the help of a $1.7 million grant from the National Institutes of Health (NIH).

Parkinson's disease is a degenerative neurological disorder involving the death of dopamine-producing cells, or neurons, deep within the brain. Depression is highly prevalent in Parkinson's disease, previous research has found.

Principal investigator Kim Seroogy, PhD, and co-investigator James Herman, PhD, are studying a stress-induced model of depression and Parkinson's in rodents. Seroogy is a professor of neurology and director of the Selma Schottenstein Harris Lab for Research in Parkinson's at the James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders. Herman is a professor of psychiatry and director of the university's neuroscience graduate program.

Parkinson's-induced rodents are stressed in a variety of ways, such as being placed briefly in a cold room or a crowded setting. In studying the results, the UC team hopes to gain insight into a problem Seroogy likens to the classic chicken-and-egg question: Which comes first, Parkinson's or depression?

"There are two schools of thought on co-morbidity of depression and Parkinson's," says Seroogy. "One is that the onset of depression precedes and possibly leads to Parkinson's. The other is that Parkinson's disease predisposes for depression. Clinically, there's evidence for both of those lines of thinking."

The NIH grant will enable the UC team to examine the question and, as Seroogy puts it, "have it surrounded."

"We're going to have some groups that undergo depression first, then the Parkinson's, and then we'll do the reverse," he says. "Then there will be some that are combined—depression, then parkinsonism, then further depression."

In pilot models so far, Seroogy and Herman have found that in those animals that have stress combined with Parkinson's, their normal loss of dopamine cells in the brain is accelerated. In addition, the movements of their impaired limbs also worsened in the behaviors that were tested.

"So stress-induced depression exacerbates problems with movement, and also causes the relevant brain cells to die faster," Seroogy says.

Learning more about the relationship between depression and Parkinson's will provide insight into possible treatments of Parkinson's, Seroogy says.

"You might ask, 'Why don't we just prescribe antidepressants?'" he adds. "Well, we do. But there are no really definitive epidemiological studies or long-term assessments of the effects of antidepressants on the progression of Parkinson's."

Seroogy and Herman will explore that, plus the possibility that antidepressants can protect the brain from Parkinson's disease.

"Not only could they reduce depression, but they might actually protect dopamine cells in the brain and thus slow the progression of Parkinson's," says Seroogy.

Seroogy and Herman began their research into depression and Parkinson's with a $14,000 grant from the Sunflower Revolution Encore, a private fund-raiser hosted by Melody Sawyer Richardson in 2005. Two years later, they received a $50,000 grant from the Davis Phinney Foundation to continue their research, which was also supported in the interim by about $20,000 from the Parkinson's Disease Support Network of Ohio, Kentucky and Indiana.

"We're gratified that an investment in our research by the local community and the Davis Phinney Foundation has now led to a five-year NIH grant that will allow us to investigate how stress causes enhanced parkinsonian symptoms, and how to prevent stress from causing further damage to the parkinsonian brain," says Seroogy.

Source: University of Cincinnati

Related stories:

Breakthrough in cell-type analysis offers new ways to study development and disease
(PhysOrg.com) -- Like skilled assassins, many diseases seem to know exactly what types of cells to attack. While decimating one cadre of cells, diseases will inexplicably spare a seemingly identical group of neighbors. What makes cells vulnerable or not depends largely on the kinds and amounts of proteins they produce — their “translational profile,” in the lingo of molecular biology. For this reason, scientists have struggled to parse the subtle molecular differences among the hundreds of specialized cell types that are tangled together in tissues like the brain.
Carbon Nanotube-Coated Electrodes Improve Brain Readouts
A research group has significantly improved the quality of brain-function measurements by coating metal neural electrodes with carbon nanotubes. Their work could potentially allow scientists to learn more about brain diseases that are based on electrical impulse malfunctions, such as Parkinson's and epilepsy.
Memory lane: Older persons with more schooling spend fewer years with cognitive loss
Those with at least a high school education spend more of their older years without cognitive loss – including the effects of Alzheimer’s, Parkinson’s and dementia -- but die sooner after the loss becomes apparent, reveals a new study appearing in the June 2008 issue of the Journal of Aging and Health.
New drug may help rescue the aging brain
As people age, their brains pay the price — inflammation goes up, levels of certain neurotransmitters go down, and the result is a plethora of ailments ranging from memory impairment and depression to Alzheimer’s and Parkinson’s. But in a long-term study with implications to treat these and other conditions, researchers have found that an experimental drug, taken chronically, has the ability to stem the effects of aging in the rat brain.
A fly's tiny brain may hold huge human benefits
Before swatting at one of those pesky flies that come out as the days lengthen and the temperature rises, one should probably think twice. A University of Missouri researcher has found, through the study of Drosophila (a type of fruit fly), that by manipulating levels of certain compounds associated with the “circuitry” of the brain, key genes related to memory can be isolated and tested. The results of the study may benefit human patients suffering from Parkinson’s disease and could eventually lead to discoveries in the treatment of depression.
For treating advanced Parkinson's, new research points to serotonin
For most people with Parkinson’s disease, the only relief from the tremors, rigidity and impaired movement associated with the progressive loss of their motor skills is a drug called L-DOPA. But as the disease progresses, L-DOPA can cause prominent side effects that counteract its effectiveness.
Sleep chemical central to effectiveness of deep brain stimulation
A brain chemical that makes us sleepy also appears to play a central role in the success of deep brain stimulation to ease symptoms in patients with Parkinson’s disease and other brain disorders. The surprising finding is outlined in a paper published online Dec. 23 in Nature Medicine.
Scientists develop non-invasive method to track nerve-cell development in live human brain
A team of scientists including researchers at Cold Spring Harbor Laboratory (CSHL) have identified and validated the first biomarker that permits neural stem and progenitor cells (NPCs) to be tracked, non-invasively, in the brains of living human subjects. This important advance could lead to significantly better diagnosis and monitoring of brain tumors and a range of serious neurological and psychiatric disorders.

News discussion:

Medicine & Health news